Simpler Grants.gov #PAR-25-352

NIH Research Funding for Drug and Device Development in Mental Health

The National Institutes of Health (NIH) is inviting applications for research funding under the National Cooperative Drug/Device Discovery/Development Groups (NCDDG) program to advance treatments for mental disorders. - Government Buyer: - National Institutes of Health (NIH) - Scope of Opportunity: - Supports discovery, preclinical development, and proof of concept testing for new drugs, devices, and neurostimulation approaches targeting mental disorders, substance use disorders (SUDs), and alcohol use disorder (AUD) - Includes development of novel ligands and circuit-engagement devices for target validation - OEMs and Vendors: - No specific OEMs or vendors are named; this is a research grant opportunity - Products/Services Requested: - No defined products, part numbers, or purchase quantities specified - Focus is on research and development projects, not procurement of specific goods or services - Unique/Notable Requirements: - Encourages partnerships between academia and industry - Open to a wide range of eligible applicants, including educational institutions, nonprofits, government entities, and businesses - Emphasis on innovative, rationally based candidate agents and devices for mental health treatment

Description

This Notice of Funding Opportunity (NOFO) encourages applications to advance the discovery, preclinical development, and proof of concept testing of new candidate agents and neurostimulation approaches to treat mental disorders, substance use disorders, or alcohol use disorder. It also supports the development of novel ligands and circuit-engagement devices to characterize or validate drug/device targets. The NOFO supports discrete projects performed by named investigators and encourages partnerships between academia and industry. Projects seeking support for multiple projects directed toward a major objective should consider the companion U19 FOA.

View original listing